Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-01-02 @ 11:42 PM
Study NCT ID:
NCT05048056
Status:
TERMINATED
Last Update Posted:
2025-02-26
First Post:
2021-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Akesobio Australia Pty Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-09
First Submit QC Date:
None
Study First Post Date:
2021-09-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-24
Last Update Post Date:
2025-02-26
Last Update Post Date Type:
ACTUAL